Interventional Neurology - Medical Devices Pipeline Assessment, 2017

Transcription

1 Interventional Neurology - Medical Devices Pipeline Assessment, 2017

2 Interventional Neurology - Medical Devices Pipeline Assessment, 2017 BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years. BioPortfolio offers a personal service to our customers with dedicated research managers who will work with you to source the best report for your needs. Based in the UK, BioPortfolio is well positioned to coordinate our customers' orders sourced from over 50 global report publishers. We are pleased to present details of this report to assist your buying decision and administrative process. You will find easy-to-use How To Buy information on the last page of this document. We look forward to being of service to you. If you have bulk and/or recurring requirements, please get in touch - we can liaise with publishers to obtain sample pages and negotiate discounts on your behalf. Phone: +44 (0) or reportstore@bioportfolio.com 2

3 Interventional Neurology - Medical Devices Pipeline Assessment, 2017 Interventional Neurology - Medical Devices Pipeline Assessment, 2017 Summary GlobalData's Medical Devices sector report, Interventional Neurology - Medical Devices Pipeline Assessment, 2017" provides an overview of Interventional Neurology currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Interventional Neurology pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts. *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type. Scope - Extensive coverage of the Interventional Neurology under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Interventional Neurology and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry Reasons to buy The report enables you to - - Formulate significant competitor information, analysis, and insights to improve R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of Interventional Neurology under development 3

4 - Develop market-entry and market expansion strategies - Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline - In-depth analysis of the product s current stage of development, territory and estimated launch date Additional Details Publisher : Global Data Reference : GDME0339EPD Number of Pages : 291 Report Format : PDF Publisher Information : 4

5 Table Of Contents for Interventional Neurology - Medical Devices Pipeline Assessment, 2017 [Report Updated: ] 1 Table of Contents1 Table of Contents 21.1 List of Tables 81.2 List of Figures 142 Introduction Interventional Neurology Overview 153 Products under Development Interventional Neurology - Pipeline Products by Stage of Development Interventional Neurology - Pipeline Products by Segment Interventional Neurology - Pipeline Products by Territory Interventional Neurology - Pipeline Products by Regulatory Path Interventional Neurology - Pipeline Products by Estimated Approval Date Interventional Neurology - Ongoing Clinical Trials 214 Interventional Neurology - Pipeline Products under Development by Companies Interventional Neurology Companies - Pipeline Products by Stage of Development Interventional Neurology - Pipeline Products by Stage of Development 255 Interventional Neurology Companies and Product Overview Alcyone Lifesciences Inc Company Overview Amnis Therapeutics Ltd Company Overview Anaconda BioMed SL Company Overview Aneuclose LLC Company Overview Apeliotus Technologies Company Overview Arterain Medical Inc (Inactive) Company Overview Avantec Vascular Corporation Company Overview BioCure, Inc. Company Overview Ceretrieve Ltd Company Overview Codman & Shurtleff Inc Company Overview Collagen Matrix Inc Company Overview Cordis Corp Company Overview CranioVation Company Overview CVTec Cerebrovascular Technologies GmbH Company Overview Dartmouth College Company Overview DePuy Synthes Inc Company Overview EchoGuide Medical, Inc. (Inactive) Company Overview Ecole Polytechnique Federale de Lausanne Company Overview Gaudi Vascular, Inc. Company Overview Hansen Medical Inc Company Overview Hansjorg Wyss Institute for Biologically Inspired Engineering Company Overview Hibernia Medical Company Overview Insera Therapeutics, LLC Company Overview InspireMD Inc Company Overview Medikit Co Ltd Company Overview Medtronic plc Company Overview Merlin MD Pte. Ltd. Company Overview Metactive Medical LLC Company Overview MicroPort Scientific Corp Company Overview MicroVention, Inc. Company Overview MindFrame Inc Company Overview MiVi Neuroscience, LLC Company Overview MRI Interventions Inc Company Overview NEOS Surgery SL Company Overview Neuravi Ltd Company Overview NeuroInterventional Therapeutics, Inc. Company Overview NeuroInterventions Company Overview Neurosigma Inc Company Overview Neurosyntec LLC. (Inactive) Company Overview NexGen Medical Systems Inc Company Overview NSVascular, Inc. Company Overview Oxford Endovascular Limited Company Overview Palmaz Scientific Inc Company Overview Penumbra Inc Company Overview Philips Healthcare Company Overview PhotoThera Inc (Inactive) Company Overview Pulsar Vascular, Inc. Company Overview Pulse Therapeutics Inc Company Overview Rapid Medical Company Overview Rontis AG Company Overview Shape Memory Therapeutics, Inc. Company Overview Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview Strategic Polymer Sciences, Inc Company Overview Taewoong Medical Co Ltd Company Overview Terumo Corp Company Overview Triticum Medical Ltd. Company Overview Twin Star Medical Inc Company Overview University of California Los Angeles Company Overview University of California San Francisco Company Overview University of Minnesota Company Overview University of South Florida Company Overview University of Wisconsin Madison Company Overview University of Wolverhampton Company Overview Valor Medical Inc Company Overview Vascular Solutions Inc Company Overview Viket Medical Corporation Company Overview Weill Cornell Medical College Company Overview Zoll Medical Corporation Company Overview 1426 Interventional Neurology- Recent Developments May 11, 2017: Healthcare Veteran John Fletcher Joins MRI Interventions Board of Directors May 09, 2017: Penumbra Reports First Quarter 2017 Financial Results May 09, 2017: Voyager Therapeutics Reports First Quarter 2017 Financial Results and Corporate Highlights May 04, 2017: AxoGen Reports 2017 First Quarter Financial Results Apr 27, 2017: Boston Scientific Announces Results For First Quarter Apr 27, 2017: MRI Interventions Announces 2017 First Quarter Results Apr 27, 2017: Merit Medical Reports Results for First Quarter of Apr 25, 2017: Stryker reports first quarter 2017 results Apr 24, 2017: Publication Provides Guidelines to Reduce Transportation Risks Associated 5

6 with Neurosurgical Laser Ablation Multi-site Workflows Apr 24, 2017: Medtronic Announces Most Advanced StealthStation for Neurosurgery Apr 24, 2017: Anaconda Biomed Engages Creganna Medical Apr 24, 2017: Nexstim Appoints Hanna Kotola as VP of Legal Affairs Apr 23, 2017: Bard Announces First Quarter Results Apr 21, 2017: Penumbra Appoints Bridget O'Rourke to its Board of Directors Apr 19, 2017: ClearPoint Neuro Navigation System s Real-time MRI Guided Platform to be Featured at AANS Practical Clinics for Fourth Consecutive Year Apr 19, 2017: Johnson & Johnson reports Q results Apr 18, 2017: Johnson & Johnson Reports 2017 First-Quarter Results Apr 11, 2017: Stroke patients in England set to receive revolutionary new treatment Apr 06, 2017: MRI Interventions Announces Record Quarterly Revenue, Record ClearPoint System Procedures in 2017 First Quarter Apr 06, 2017: MRI Interventions Announces Record Quarterly Revenue, Record ClearPoint System Procedures in 2017 First Quarter Apr 04, 2017: $3.6 million to fund personalized 3-D brain maps to guide neurosurgeries Mar 30, 2017: MPSC Announces 2016 Annual Results Mar 28, 2017: Nexstim: The decisions of the Board of Directors Mar 23, 2017: Synaptive Medical Expands Medtech Expertise Through Board Additions Mar 21, 2017: Metactive Medical Announces Issuance of Patent on Ballstent Embolization Device Mar 20, 2017: MicroPort NeuroTech Hosts WILLIS Academic Symposium Mar 15, 2017: Voyager Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Corporate Highlights Mar 13, 2017: Cook Medical Announces Umesh Patel as President of Cook Biotech Mar 09, 2017: Changes in Nexstim Management Team Mar 07, 2017: MicroVention And Terumo Announce Data From Multicenter GREAT Study Mar 07, 2017: Anteo Technologies Announces Verification Study With Cook Medical Australia Feb 28, 2017: Nexstim: Financial Statement Release Feb 28, 2017: MRI Interventions Announces 2016 Fourth Quarter and Full Year Results Feb 28, 2017: Penumbra Reports Fourth Quarter and Full Year 2016 Financial Results Feb 28, 2017: Government of Canada Invests in Research to Advance Patient Care Feb 23, 2017: New Solitaire Stent Retriever Study Validates Outcomes and Real-World Application of Stroke Treatment Best Practices Feb 22, 2017: Independent Study Supports Use of Penumbra Aspiration as Frontline Thrombectomy Therapy for Acute Ischemic Stroke Feb 22, 2017: AxoGen Reports 2016 Fourth Quarter and Full Year Financial Results Feb 21, 2017: Neuravi Announces Completion of Patient Enrollment in Clinical Trial of a Novel Stent Retriever for Acute Ischemic Stroke Feb 21, 2017: Medtronic Reports Third Quarter Financial Results Feb 21, 2017: Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, Feb 16, 2017: InspireMD Provides Year End Business Update and Reports Financial Results for the Fourth Quarter and Year Ended December 31, Feb 14, 2017: MicroPort Receives CFDA Approval for APOLLO Intracranial Stent System in Large Sizes Feb 09, 2017: Terumo Announces Change of Executive Officers Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, Jan 31, 2017: Terumo Opens a Branch in Yangon Jan 26, 2017: Bard Announces Fourth Quarter Results Jan 24, 2017: Stryker reports 2016 results and 2017 outlook Jan 24, 2017: Johnson & Johnson Reports 2016 Fourth-Quarter Results Jan 24, 2017: MRI Interventions Announces Year-End Update, Including 2016 Fourth Quarter and Full Year Revenues Jan 16, 2017: MicroPort Attends 19th Annual Meeting of China Health Economics Association Jan 10, 2017: Stryker provides 2016 preliminary net sales results Jan 09, 2017: Anaconda BioMed Appoints Mr. Giovanni Leo to its Advisory Board Jan 09, 2017: AxoGen Preannounces Estimated Fourth Quarter and Full Year 2016 Revenue Jan 09, 2017: Johnson & Johnson Medical Devices Companies Launch CareAdvantage, a Suite of Holistic, Insights-Driven Capabilities to Help U.S. Health Systems Navigate Value- Based Care Jan 05, 2017: AxoGen Appoints Ivica Ducic Medical Director Jan 05, 2017: Voyager Therapeutics Elects Wendy Dixon, Ph.D. and Glenn Pierce, M.D., Ph.D. to Board of Directors Jan 04, 2017: MRI Interventions ClearPoint Surpasses Single-Year Milestone of 500 Procedures in Jan 03, 2017: Amnis Therapeutics Starts its First Clinical Trial with its Neuro Thrombectomy Device Jan 03, 2017: Voyager Therapeutics Appoints Jane Pritchett Henderson as Chief Financial Officer 2057 Appendix Methodology About GlobalData Contact Us Disclaimer 290 6

7 List Of Tables in Interventional Neurology - Medical Devices Pipeline Assessment, 2017 [Report Updated: ] 1.1 List of Tables Table 1: Interventional Neurology - Pipeline Products by Stage of Development 17 Table 2: Interventional Neurology - Pipeline Products by Segment 18 Table 3: Interventional Neurology - Pipeline Products by Territory 19 Table 4: Interventional Neurology - Pipeline Products by Regulatory Path 20 Table 5: Interventional Neurology - Pipeline Products by Estimated Approval Date 21 Table 6: Interventional Neurology - Ongoing Clinical Trials 22 Table 7: Interventional Neurology Companies - Pipeline Products by Stage of Development 23 Table 8: Interventional Neurology - Pipeline Products by Stage of Development 26 Table 9: Alcyone Lifesciences Inc Pipeline Products & Ongoing Clinical Trials Overview 29 Table 10: Alcyone Microcatheter - Product Status 29 Table 11: Alcyone Microcatheter - Product Description 29 Table 12: Amnis Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview 30 Table 13: Golden Retriever - Product Status 30 Table 14: Golden Retriever - Product Description 30 Table 15: Amnis Therapeutics Ltd - Ongoing Clinical Trials Overview 31 Table 16: Golden Retriever - Amnis Therapeutics Thrombectomy Device-First in Man (FIM) Safety and Performance Study 32 Table 17: Anaconda BioMed SL Pipeline Products & Ongoing Clinical Trials Overview 33 Table 18: ANCD BRAIN - Product Status 33 Table 19: ANCD BRAIN - Product Description 33 Table 20: Aneuclose LLC Pipeline Products & Ongoing Clinical Trials Overview 34 Table 21: Aneurysm Occlusion Saddle - Product Status 34 Table 22: Aneurysm Occlusion Saddle - Product Description 34 Table 23: Janjua Aneurysm Net - Product Status 35 Table 24: Janjua Aneurysm Net - Product Description 35 Table 25: Apeliotus Technologies Pipeline Products & Ongoing Clinical Trials Overview 36 Table 26: Polymer Stent for Cerebral Aneurysms - Product Status 36 7

8 Table 27: Polymer Stent for Cerebral Aneurysms - Product Description 36 Table 28: Arterain Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 37 Table 29: Catheter Based System - Product Status 37 Table 30: Catheter Based System - Product Description 37 Table 31: Avantec Vascular Corporation Pipeline Products & Ongoing Clinical Trials Overview 38 Table 32: Endovascular Embolization Device - Product Status 38 Table 33: Endovascular Embolization Device - Product Description 38 Table 34: Ischemic Stroke Therapy Device - Product Status 39 Table 35: Ischemic Stroke Therapy Device - Product Description 39 Table 36: BioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40 Table 37: GelCoil - Product Status 40 Table 38: GelCoil - Product Description 40 Table 39: Ceretrieve Ltd Pipeline Products & Ongoing Clinical Trials Overview 41 Table 40: Device - Ischemic Stroke - Product Status 41 Table 41: Device - Ischemic Stroke - Product Description 41 Table 42: Codman & Shurtleff Inc Pipeline Products & Ongoing Clinical Trials Overview 42 Table 43: Covered Stent - Product Status 42 Table 44: Covered Stent - Product Description 42 Table 45: Next Generation Balloon Expandable Stent - Product Status 43 Table 46: Next Generation Balloon Expandable Stent - Product Description 43 Table 47: Next Generation REVIVE SE - Product Status 43 Table 48: Next Generation REVIVE SE - Product Description 44 Table 49: Self-Expanding Stent - Product Status 44 Table 50: Self-Expanding Stent - Product Description 44 Table 51: Collagen Matrix Inc Pipeline Products & Ongoing Clinical Trials Overview 45 Table 52: Collagen-based Coils - Product Status 45 Table 53: Collagen-based Coils - Product Description 45 Table 54: Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 46 Table 55: Flow Diverter - Product Status 46 Table 56: Flow Diverter - Product Description 46 Table 57: CranioVation Pipeline Products & Ongoing Clinical Trials Overview 47 8

9 Table 58: Brain Aneurysm Clip - Product Status 47 Table 59: Brain Aneurysm Clip - Product Description 47 Table 60: CVTec Cerebrovascular Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 48 Table 61: CoilAlarm - Product Status 48 Table 62: CoilAlarm - Product Description 48 Table 63: Dartmouth College Pipeline Products & Ongoing Clinical Trials Overview 49 Table 64: Aneurysm Clip Applicator - Product Status 49 Table 65: Aneurysm Clip Applicator - Product Description 49 Table 66: Cerebral Aneurysm Clip - Product Status 50 Table 67: Cerebral Aneurysm Clip - Product Description 50 Table 68: DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 51 Table 69: Liquid Embolic System - Product Status 51 Table 70: Liquid Embolic System - Product Description 51 Table 71: Occlusion Balloons - Product Status 52 Table 72: Occlusion Balloons - Product Description 52 Table 73: EchoGuide Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 53 Table 74: Ultrasound Catheter Navigation Device - Product Status 53 Table 75: Ultrasound Catheter Navigation Device - Product Description 53 Table 76: Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview 54 Table 77: e-dura Implant - Product Status 54 Table 78: e-dura Implant - Product Description 54 Table 79: Gaudi Vascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55 Table 80: Intracranial Stent - Product Status 55 Table 81: Intracranial Stent - Product Description 55 Table 82: Hansen Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 56 Table 83: Magellan Robotic System - Neurological Indication - Product Status 56 Table 84: Magellan Robotic System - Neurological Indication - Product Description 56 Table 85: Hansjorg Wyss Institute for Biologically Inspired Engineering Pipeline Products & Ongoing Clinical Trials Overview 57 Table 86: Blood Clots Clearing Device - Product Status 57 Table 87: Blood Clots Clearing Device - Product Description 57 9

10 Table 88: Hibernia Medical Pipeline Products & Ongoing Clinical Trials Overview 58 Table 89: Hybernia Safety Catheter - Neuroprotection - Product Status 58 Table 90: Hybernia Safety Catheter - Neuroprotection - Product Description 58 Table 91: Insera Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 59 Table 92: SHELTER - Product Status 59 Table 93: SHELTER - Product Description 59 Table 94: InspireMD Inc Pipeline Products & Ongoing Clinical Trials Overview 60 Table 95: NVGuard Neurovascular - Product Status 60 Table 96: NVGuard Neurovascular - Product Description 60 Table 97: Medikit Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 61 Table 98: Aspirarecath - Product Status 61 Table 99: Aspirarecath - Product Description 62 Table 100: Axcelguide - Product Status 62 Table 101: Axcelguide - Product Description 62 Table 102: Cerulean G - Product Status 63 Table 103: Cerulean G - Product Description 63 Table 104: Slimguide - Product Status 63 Table 105: Slimguide - Product Description 64 Table 106: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 65 Table 107: Artisse Intrasaccular Device - Product Status 65 Table 108: Artisse Intrasaccular Device - Product Description 66 Table 109: Lazarus Cover - Product Status 66 Table 110: Lazarus Cover - Product Description 66 Table 111: Lazarus ReCover - Product Status 67 Table 112: Lazarus ReCover - Product Description 67 Table 113: Medina Embolization Device - Product Status 67 Table 114: Medina Embolization Device - Product Description 68 Table 115: Pipeline Flex w/shield - Surface Enhancement - Product Status 68 Table 116: Pipeline Flex w/shield - Surface Enhancement - Product Description 68 Table 117: UNO Neurovascular Embolization System - Product Status 69 Table 118: UNO Neurovascular Embolization System - Product Description 69 10

11 Table 119: Medtronic plc - Ongoing Clinical Trials Overview 70 Table 120: Medina Embolization Device - Medina Embolization Device in Neurovascular Aneurysms Study - A Post Market Clinical Follow-up Study: The MEDINA Study 71 Table 121: Merlin MD Pte. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 72 Table 122: Next Generation Device For Cerebral Aneurysm - Product Status 72 Table 123: Next Generation Device For Cerebral Aneurysm - Product Description 72 Table 124: Metactive Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 73 Table 125: Ballstent Microcatheter - Product Status 73 Table 126: Ballstent Microcatheter - Product Description 73 Table 127: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 74 Table 128: Clot Retrieval Device - Product Status 74 Table 129: Clot Retrieval Device - Product Description 74 Table 130: Embolization Coils - Product Status 75 Table 131: Embolization Coils - Product Description 75 Table 132: Micro-Catheter - Product Status 75 Table 133: Micro-Catheter - Product Description 76 Table 134: Tubridge - Product Status 76 Table 135: Tubridge - Product Description 76 Table 136: Vertebral Artery Stent - Product Status 77 Table 137: Vertebral Artery Stent - Product Description 77 Table 138: MicroPort Scientific Corp - Ongoing Clinical Trials Overview 78 Table 139: Embolization Coils - Prospective, Randomized, Controlled, Open Label, All China, Multi-center, Registration Trial of the Microport Neurotech Coil Embolization System for the Treatment of Intracranial Aneurysms 79 Table 140: MicroVention, Inc. Pipeline Products & Ongoing Clinical Trials Overview 80 Table 141: Advanced Coil - Product Status 80 Table 142: Advanced Coil - Product Description 80 Table 143: Advanced WEB Aneurysm Embolization Device - Product Status 81 Table 144: Advanced WEB Aneurysm Embolization Device - Product Description 81 Table 145: Coated Stent - Product Status 81 Table 146: Coated Stent - Product Description 82 Table 147: ERIC Retrieval Device - Product Status 82 11

12 Table 148: ERIC Retrieval Device - Product Description 82 Table 149: FRED Flow-Diverting Stent - Product Status 83 Table 150: FRED Flow-Diverting Stent - Product Description 83 Table 151: WEB Aneurysm Embolization System - Product Status 83 Table 152: WEB Aneurysm Embolization System - Product Description 84 Table 153: MicroVention, Inc. - Ongoing Clinical Trials Overview 85 Table 154: WEB Aneurysm Embolization System - Clinical Assessment of Web Device in Ruptured Aneurysms 86 Table 155: WEB Aneurysm Embolization System - CLinical Assessment of WEB Device in Ruptured aneurysms (CLARYS): CLARYS 86 Table 156: WEB Aneurysm Embolization System - The WEB Intrasaccular Therapy Study (WEB-IT) 86 Table 157: WEB Aneurysm Embolization System - WEB Clinical Assessment of IntraSaccular Aneurysm Therapy 87 Table 158: WEB Aneurysm Embolization System - WEB French Observatory 87 12

13 List Of Figures, Charts and Diagrams in Interventional Neurology - Medical Devices Pipeline Assessment, 2017 [Report Updated: ] 1.2 List of Figures Figure 1: Interventional Neurology - Pipeline Products by Stage of Development 17 Figure 2: Interventional Neurology - Pipeline Products by Segment 18 Figure 3: Interventional Neurology - Pipeline Products by Territory 19 Figure 4: Interventional Neurology - Pipeline Products by Regulatory Path 20 Figure 5: Interventional Neurology - Pipeline Products by Estimated Approval Date 21 Figure 6: Interventional Neurology - Ongoing Clinical Trials 22 13

14 How to Buy... Interventional Neurology - Medical Devices Pipeline Assessment, 2017 [Report Updated: ] Option 1 - Online Go to our website and pay online with any major debit or credit card: Option 2 - Request a Proforma Invoice Fill in the details below, and either Scan this page and it to us at reportstore@bioportfolio.com or Fax it to us at +44 (0) We will send you a Proforma Invoice and deliver your report on settlement. Your Name: Job Title: Your Your Contact Phone: Company Name: Address: Post/Zip Code: Country: P.O. Number: Any Other Instructions: Pricing Options: (please tick one) $4000 Single User Price $8000 Site License Price $12000 Enterprise License Price Payment Options: (please tick one) Online Credit Card (we will you the invoice with a payment link) Direct Wire Transfer (we will you the invoice with our bank details) Authorising Signature: Option 3 - Phone Us on +44 (0) We will be delighted to give you our personal attention. 14